Nephros Inc (NEPH)

NASDAQ

Currency in USD

4.020

-0.060(-1.47%)

Closed·21/08

After Hours

4.0200.000(0.00%)

·21/08

Fair Value

Unlock Value

Day's Range

4.010

4.130

52 wk Range

1.364

5.000

NEPH Financial Summary

A brief financial summary of Nephros Inc as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

Key Ratios

P/E Ratio35.66

Price/Book4.69

Debt / Equity12.93%

Return on Equity15.14%

Dividend Yield0.00%

EBITDA143.00K

Fair ValueUnlock

Fair Value UpsideUnlock

Statements Highlights

Period Ending:

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

Income Statement

Total Revenues

aa.aa

8.56

10.22

9.98

14.24

14.16

Gross Profit

aa.aa

4.91

5.63

4.73

8.41

8.72

Operating Income

aa.aa

-4.5

-3.25

-4.34

-1.59

0.01

Net Income

aa.aa

-4.77

-4.11

-7.38

-1.58

0.07

Balance Sheet

Total Assets

aa.aa

18.51

17.65

11.86

11.21

Total Current Liabilities

aa.aa

1.33

2.39

1.41

2.11

1.56

Total Equity

aa.aa

15.57

14.75

8.88

8.36

8.59

Cash Flow

Levered Free Cash Flow

aa.aa

-5.54

0.7

-0.33

1.37

-0.65

Cash from Operations

aa.aa

-6.9

-1.42

-3.23

0.83

-0.49

Cash from Investing

aa.aa

-0.24

-0.09

-0.14

-0.08

-0.05

Cash from Financing

aa.aa

11.22

0.24

0.03

-0.08

-0.01

Net Change in Cash

aa.aa

4.08

-1.28

-3.34

0.67

-0.55

* In Millions of USD (except for per share items)

Analyst Ratings

2 Buy

0 Hold

0 Sell

Ratings:

2 analysts

Overall Consensus

Strong Buy

Analysts 12-Month Price Target:

Average 5.500

(+36.82% Upside)

Earnings

Latest Release

Aug 07, 2025

EPS / Forecast

0.02 / -0.01

Revenue / Forecast

4.40M / 3.60M

EPS Revisions

Unlock

Last 90 days

FAQ

What were Nephros's earnings for the latest quarter?

The Nephros EPS (TTM) is 0.13. Nephros reported sales of 4.42, net income of 0.24, and EPS of 0.02 for the latest quarter.

What was Nephros's net income for the latest quarter?

Nephros's net income for the latest quarter was 0.24.

How did Nephros's performance compare year-over-year in the latest quarter?

The company's revenue moved from 4.88 in the previous quarter to 4.42 in the latest quarter, and net income moved from 0.56 to 0.24 compared to the previous quarter.

What is Nephros's net profit margin on a TTM basis?

Nephros's trailing twelve months (TTM) net profit margin is 0.52%.

How does Nephros's debt to equity ratio compare to industry standards?

Nephros's total debt-to-equity ratio is 12.93%.

What is Nephros's return on investment on a TTM basis?

Nephros's trailing twelve months (TTM) return on investment (ROI) is 15.14%.

Did Nephros gain or lose cash last quarter?

In the latest quarter, Nephros's net change in cash was 0.99 million.

What were Nephros's total assets and liabilities in the latest quarter?

As of the latest quarter, Nephros reported total assets of 12.24 million and total liabilities of 1.77 million.

How has Nephros's total revenue grown this year?

Nephros's total revenue was 4.88 in the previous quarter and 4.42 in the latest quarter.

What is Nephros's gross margin on a TTM basis?

Nephros's trailing twelve months (TTM) gross margin is 63.37%.

What was Nephros's revenue per share for the latest quarter?

Nephros's revenue per share for the latest quarter was 34.82.

NSE 30

5,124.12

+3.09

+0.06%

NSE All Share

140,612.12

+279.69

+0.20%

US 30

44,904.50

+119.0

+0.27%

US 500

6,383.90

+13.7

+0.22%

FTSE 100

9,312.55

+3.35

+0.04%

DAX

24,294.03

+2.71

+0.01%

South Africa Top 40

94,503.70

+383.30

+0.41%

Market Movers

Name	Last	Chg. %	Vol.
Transcorp Power	258.00	-9.95%	29.72M
Fidelitybk	20.850	+0.48%	17.04M
Guaranty Trust Holding	92.50	-0.27%	13.59M
STANBIC IBTC Bank	94.00	-0.53%	13.02M
UBA	47.95	-0.10%	12.42M
Aradel Holdings	501.00	-3.47%	493.71K
Geregu Power	1,027.40	-10.00%	439.58K

Name	Last	Chg. %	Vol.
UPDC	6.93	+10.00%	1.51M
FTN Cocoa Processors PLC	6.60	+10.00%	1.57M
Veritas Kapital	1.98	+10.00%	17.07M
SCOA Nigeria	6.050	+10.00%	17.63K
Skye Shelter Fund	301.55	+9.99%	1.49K
Sovereign Trust Insurance Plc	2.65	+9.96%	15.53M
Ncr Nigeria	10.50	+9.95%	108.10K

Name	Last	Chg. %	Vol.
Infinity Trust Mortgage Bank	6.30	-10.00%	12.36K
Nigerian Enamelware PLC	35.10	-10.00%	12.43K
Chellarams	9.45	-10.00%	9.86K
Geregu Power	1,027.40	-10.00%	439.58K
Daarcomm	1.14	-5.79%	850.59K
Thomaswy	3.00	-9.91%	1.11M
Industrial Medical Gases Nigeria	33.35	-9.86%	81.67K

Trending Stocks

Name	Last	Chg. %	Vol.
Jaiz Bank	4.75	+8.20%	9.55M
Ellah Lakes	15.95	+3.57%	3.45M
Champion Brew	17.95	+0.28%	3.03M
Oando Plc	49.00	+0.72%	899.53K
Guaranty Trust Holding	92.50	-0.27%	13.59M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aa Aaaaaaa	5,388.90	+52.49%	8,217.53
Aaaaaaaa Aaaaaa	516.00	+42.69%	736.28
Aaaa Aa A Aa Aa	1,869.10	+37.98%	2,578.98
Aaa Aaa A A Aa A Aa	64.40	+30.14%	83.81
Aa Aaaaaa A A	139.50	+26.08%	175.88
Aaaaaaa	619.90	+16.59%	722.74

Name	Last	Upside	Fair Value
Aa Aaaaaaa	5,388.90	+52.49%	8,217.53
Aaaaaaaa Aaaaaa	516.00	+42.69%	736.28
Aaaa Aa A Aa Aa	1,869.10	+37.98%	2,578.98
Aaa Aaa A A Aa A Aa	64.40	+30.14%	83.81
Aa Aaaaaa A A	139.50	+26.08%	175.88
Aaaaaaa	619.90	+16.59%	722.74

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers

Popular Searches

Please try another search

Nephros Inc (NEPH)

NEPH Financial Summary

Key Ratios

Statements Highlights

Analyst Ratings

Analysts 12-Month Price Target:

Earnings

FAQ

What were Nephros's earnings for the latest quarter?

What was Nephros's net income for the latest quarter?

How did Nephros's performance compare year-over-year in the latest quarter?

What is Nephros's net profit margin on a TTM basis?

How does Nephros's debt to equity ratio compare to industry standards?

What is Nephros's return on investment on a TTM basis?

Did Nephros gain or lose cash last quarter?

What were Nephros's total assets and liabilities in the latest quarter?

How has Nephros's total revenue grown this year?

What is Nephros's gross margin on a TTM basis?

What was Nephros's revenue per share for the latest quarter?

Trending Stocks